医学
寄生菌
子宫内膜异位症
排卵
耐受性
盆腔疼痛
妇科
内科学
外科
激素
不利影响
作者
Paolo Vercellini,Laura Buggio,Maria Pina Frattaruolo,Alessandra Borghi,Dhouha Dridi,Edgardo Somigliana
标识
DOI:10.1016/j.bpobgyn.2018.01.015
摘要
Available medical treatments for symptomatic endometriosis act by inhibiting ovulation, reducing serum oestradiol levels, and suppressing uterine blood flows. For this, several drugs can be used with a similar magnitude of effect, in terms of pain relief, independently of the mechanism of action. Conversely, safety, tolerability, and cost differ. Medications for endometriosis can be categorized into low-cost drugs including oral contraceptives (OCs) and most progestogens, and high-cost drugs including dienogest and GnRH agonists. As the individual response to different drugs is variable, a stepwise approach is suggested, starting with OCs or low-cost progestogens, and stepping up to high-cost drugs only in case of inefficacy or intolerance. OCs may be used in women with dysmenorrhea as their main complaint, and when only superficial peritoneal implants or ovarian endometriomas <5 cm are present, while progestogens should be preferred in women with severe deep dyspareunia and when infiltrating lesions are identified.
科研通智能强力驱动
Strongly Powered by AbleSci AI